Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping
The bromodomain and extra-terminal (BET) bromodomains, particularly BRD4, have been identified as promising therapeutic targets in the treatment of many human disorders such as cancer, inflammation, obesity, and cardiovascular disease. Recently, the discovery of novel BRD4 inhibitors has garnered su...
Saved in:
Main Authors: | Zhimin Zhang (Author), Lili Gu (Author), Beibei Wang (Author), Wenhai Huang (Author), Yanmin Zhang (Author), Zhen Ma (Author), Shenxin Zeng (Author), Zhengrong Shen (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1)
by: Zhimin Zhang, et al.
Published: (2020) -
Free energy perturbation (FEP)-guided scaffold hopping
by: Deyan Wu, et al.
Published: (2022) -
Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor
by: Jiao Li, et al.
Published: (2021) -
Discovery of SIPI6473, a New, Potent, and Orally Bioavailable Multikinase Inhibitor for the Treatment of Non-small Cell Lung Cancer
by: Xiu Gu, et al.
Published: (2021) -
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand-based drug design
by: Joana Magalhães, et al.
Published: (2018)